Champions Oncology

Historical price data

Champions Oncology (NASDAQ: CSBR) is a mission-driven oncology CRO focused on accelerating cancer drug discovery through clinically predictive research models and data analytics. The company has established a leadership position by building one of the world's largest and most deeply characterized PDX model banks, integrated with a multi-omic data ecosystem. Its fee-for-service strategy provides essential, de-risking tools to biopharma partners, positioning it as a critical enabler in the oncology R&D value chain. With a market valuation of approximately $80 million, it operates as a specialized, capital-efficient player in a high-growth sector.

Proprietary bank of over 1,400 Patient-Derived Xenograft (PDX) models integrated with the Lumin multi-omic data platform, featuring over 2 billion data points for clinically predictive oncology research.

Champions competes with large, full-service CROs (e.g., Charles River Labs) on specialization and with focused oncology CROs (e.g., Crown Bioscience) on its unique combination of a pretreated PDX model bank, integrated Lumin data platform, and hybrid preclinical/clinical service offering.